rapidly throughout the nervous system. T lymphocyte
infiltration and apoptosis of neurons were associated with death usually by 21 days after infection. As such, this model reproduces multiple aspects of MV infection in humans.
Results

Generation of Transgenic Mice and Expression of CD46 RNA and Protein
CD46-expressing transgenic mice (Yannoutsos et al., 1996) YAC CD46 line 2 (YAC-CD46) contained 10 to 12 genome copies of CD46 and expressed all four of its major isoforms (Liszewski et al., 1991; Yannoutsos et al., 1996) . After documenting integration and perpetuation of the CD46 gene for two generations, we determined the expression of CD46 RNA and protein of these mice using in situ hybridization within whole-animal sections and in Northern blots. Expression of CD46 transcripts and proteins detected within whole-animal sections (Figures 1A and 1B) was ubiquitous in YAC-CD46 transgenic mice but absent in the nontransgenic mice (6 of 6 mice studied in each group). When 4 g RNA extracted separately from brain, spleen, lymph nodes, thymus, kidney, liver, gut, and lung was blotted on nitrocellulose and hybridized with a 32 P-labeled CD46 cDNA probe, Northern blot analysis revealed that these tissues from transgenic mice expressed the 4.5 to 4.8 kb CD46 transcript. By contrast, the same amount of RNA from nontransgenic mice did not contain any CD46 transcripts (3 of 3 mice studied in each group). In another transgenic line, neuron-specific enolase (NSE)-CD46, CD46 RNA was restricted to the brain (Rall et al., 1997), but we could not detect any CD46 transcripts or proteins in whole-animal sections of these mice. Even in brains of four NSE-CD46 transgenic mice, no 32 P-labeled CD46 was evident, although by RT-PCR CD46 was readily detected (data not shown; Rall et al., 1997) , implying that the endogenous CD46 promoter more efficiently expressed CD46 than the NSE promoter. To compare the CD46 protein expression in brains of these two distinct transgenic lines, we quantitated CD46 protein on the surface of hippocampal neurons derived from either YAC-CD46 mice or NSE-CD46 mice. Neurons from YAC-CD46 mice contained at least 10-fold more CD46 molecules than neurons from NSE-CD46 mice. Data from two additional experiments showed that the concentration of CD46 in YAC-CD46 mice was 10-to 20-fold higher than in NSE-CD46 mice. Therefore, YAC-CD46 mice were used for the remainder of these studies. (Figures 1 and 3A) ; in 10-12 days the presence of similar syncytia in both CD4 ϩ T lymphocyte and macrophage cultures was usually observed. Infectious virus was recovered by day 9 or later, and at day 14 over 10 5 pfu of virus per milliliter of culture supernatant was recorded from spleen, CD8 ϩ T, and CD4 ϩ T cell cultures. Isolation of MV from whole spleen or lymphoid subsets was noted 4-7 days after i.c. inoculation of newborn (ten mice) YAC-CD46 transgenic mice. Analysis of brain at similar harvested periods indicated recovery of two logs more infectious virus at day 9 than from the spleen (Figure 3) . Immunochemical analysis indicated that MV expression was restricted almost entirely to neurons (Figure 4 ; Ͼ99% of 1000 cells counted) and was occasionally present in oligodendrocytes (Ͻ0.01%) and microglia (Ͻ0.5%). MV antigen was absent from GFAP ϩ cells. Attempts to recover virus in the absence of cocultivation failed. (Figures 5A , 5B, 5E-5G). No evidence of formed virions was phocytes removed 3 days later were unable to mount a MHC-restricted cytotoxic T lymphocyte response to noted in axons. These findings supported the concept that infectious virus was not being spread via the fluid LCMV-infected targets. In contrast, similarly harvested lymphocytes from YAC-CD46 mice that were not inphase but was likely transported as MV ribonucleoprotein complexes toward termini of neurites. 
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